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Abstract
Objective
To evaluate factors associated with rotavirus diarrhea and to describe severity of illness
among children <5 years old with non-dysenteric, moderate-to-severe diarrhea (MSD) in
rural western Kenya.
Methods
We analyzed data from children <5 years old with non-dysenteric MSD enrolled as cases in
the Global Enteric Multicenter Study (GEMS) in Kenya. A non-dysenteric MSD case was
defined as a child with3 loose stools in 24 hrs. and one or more of the following: sunken
eyes, skin tenting, intravenous rehydration, or hospitalization, who sought care at a sentinel
health center within 7 days of illness onset. Rotavirus antigens in stool samples were
detected by ELISA. Demographic and clinical information was collected at enrollment and
during a single follow-up home visit at approximately 60 days. We analyzed diarrhea
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severity using a GEMS 17 point numerical scoring system adapted from the Vesikari score.
We used logistic regression to evaluate factors associated with rotavirus infection.
Results
From January 31, 2008 to September 30, 2012, among 1,637 (92%) non-dysenteric MSD
cases, rotavirus was detected in stools of 245 (15.0%). Rotavirus-positive compared with
negative cases were: younger (median age, 8 vs. 13 months; p<0.0001), had more severe
illness (median severity score, 9 vs 8; p<0.0001) and had to be hospitalized more frequently
(37/245 [15.1%] vs. 134/1,392 [9.6%]), p <0.013). Independent factors associated with rota-
virus infection included age 0–11 months old (aOR = 5.29, 95% CI 3.14–8.89) and present-
ing with vomiting3 times/24hrs (aOR = 2.58, 95% CI [1.91–3.48]). Rotavirus was detected
more commonly in warm and dry months than in the cool and rainy months (142/691 [20%]
vs 70/673 [10%]) p<0.0001).
Conclusions
Diarrhea caused by rotavirus is associated with severe symptoms leading to hospitalization.
Consistent with other settings, infants had the greatest burden of disease.
Introduction
Diarrhea continues to be the second leading cause of death among children under 5 years
worldwide and was responsible for approximately 800,000 (~10.5%) of global deaths in this age
group in 2015 [1]. Of the 7.6 million global deaths reported among children<5 years in 2010,
9.9% were attributed to diarrheal diseases [2]. This was a remarkable decrease from the 8.9 mil-
lion reported deaths in 2008 when diarrheal diseases accounted for 15% of deaths [3]. Despite
these reductions rotavirus has remained as the most commonest cause of severe gastroenteritis
[4] and the estimated decrease in deaths associated with the disease has been reported to range
from ~500,000 deaths in 2008 among children<5 years of age, accounting for 5% of total
global deaths [5] to ~200,000 in 2015 among the same age group [6], consistent with the WHO
Child Health Epidemiology Reference Group (CHERG) estimates [1]. Approximately two-
thirds or more of these deaths continue to occur in South Asia and sub-Saharan Africa [1, 2, 4].
In Kenya, rotavirus diarrhea is estimated to cause over 19% (~9,000) of diarrhea hospitaliza-
tions, 16% (~1.5 million) of clinic visits for diarrhea and more than 4,000 deaths among chil-
dren<5 years of age annually [5, 7, 8]. More severe diarrhea and vomiting leading to severe
dehydration are common classical symptoms associated with rotavirus disease [9–11].
Currently available rotavirus vaccines have been shown to be effective in reducing the dis-
ease burden [12–16]. In July 2014, Kenya introduced rotavirus vaccine as part of the National
Immunization Program. Understanding the epidemiology of rotavirus infections in the local
setting therefore remains essential for documenting the basis for rotavirus immunization. Fur-
thermore such information is useful in guiding implementation of other concurrent interven-
tions that are effective in the prevention and treatment of diarrhea such as oral rehydration
therapy (ORT) inclusive of continued and ideally increased fluid intake and feeding during
diarrheal episodes, zinc treatment, and improvements in water and sanitation [17]. In this
study, we describe the epidemiology, seasonality, clinical features and factors associated with
rotavirus infection among children<5 years of age with non-dysenteric MSD in rural western
Kenya prior to rotavirus vaccine introduction.
Epidemiology of Rotavirus-Associated Diarrhea among Children in Rural Western Kenya⎯ 2008–2012
PLOS ONE | DOI:10.1371/journal.pone.0160060 August 5, 2016 2 / 17
Funding: This study was funded by the Bill and
Melinda Gates Foundation, Grants # 38874 (GEMS)
and #OPP10333572 (GEMS1A), Myron M. Levine
(PI) through the University of Maryland, School of
Medicine, Center for Vaccine Development,
Baltimore, MD USA. The funder had no role in the
study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
Materials and Methods
Study design
We evaluated data collected from cases enrolled in the Global Enteric Multicenter Study
(GEMS), a 4-year; prospective, age-stratified, health center-based matched case-control study
of MSD among children aged 0–59 months old residing within a defined and enumerated pop-
ulation [18–20].
Study setting
The study was conducted in the Asembo, Gem and Karemo communities in Siaya County,
(formerly Nyanza province) in rural western Kenya. The Kenya Medical Research Institute
(KEMRI) in collaboration with the U.S. Centers for Disease Control and Prevention (CDC)
has been operating a health and demographic surveillance system (HDSS) in these communi-
ties since 2001, see Fig 1. The study setting has been described further elsewhere [19, 20].
Study case definition, recruitment and laboratory methods
A non-dysenteric MSD case was defined as a child with3 loose stools in 24 hrs. and one or
more of the following: sunken eyes, skin tenting, requiring intravenous rehydration, or hospi-
talization, who sought care from outpatient or in-patient department of a study sentinel health
center (SHC) within 7 days of illness onset. In this analysis, MSD cases with dysentery were
excluded.
Caretaker’s maximum education was classified as formal education (completed primary,
secondary or post-secondary) or non-formal (incomplete primary, religious education or no
education). We classified dehydration as either mild or moderate to severe as follows: a child
was considered mildly dehydrated if 2 or more of the following were present: restless or
Fig 1. KEMRI/CDC HDSS study area (Asembo, Gem and Karemo) where GEMS Kenya Study was conducted.
doi:10.1371/journal.pone.0160060.g001
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irritable on arrival or at admission to the SHC, sunken eyes, thirsty, drank eagerly; skin pinch
goes back slowly (1–2 seconds). A child was considered moderately to severely dehydrated if 2
or more of the following were present: lethargic or unconscious on arrival or at admission to
the SHC, sunken eyes, drank poorly or unable to drink, skin pinch goes back very slowly (>2
seconds). Fever was defined by the presence of an axillary body temperature greater than or
equal to 38°C or parental perception.
At enrollment, demographic, clinical, epidemiological information and stool samples were
collected. Rotavirus VP6 antigen was detected in the whole stool specimen by a well-validated
commercial enzyme-linked immunosorbent assay (ELISA) (ProSpecT rotavirus kit, Oxford,
Basingstoke, UK). Detailed laboratory methods are described elsewhere [21]. A single home
visit ~ 60 days (targeted range 50–90 days) following enrollment was carried out to assess each
child’s health outcome from the acute diarrheal illness [8, 18]. Mortality that occurred at any
time point between initial enrollment from the SHC and the follow-up visit was recorded.
Statistical analysis
Data collection and management procedures for GEMS have been described previously [22].
Data were analyzed using SAS version 9.4 (SAS Institute, Inc. Cary, North Carolina, USA).
To compare non-dysenteric MSD cases who tested positive vs. negative for rotavirus, we
report proportions and chi square p-values for categorical variables, including mortality
recorded at ~60 days follow-up. Medians for continuous variables were compared with Wil-
coxon rank sum test. We initially explored the association between each factor and rotavirus
positivity among non-dysentery MSD cases one at a time using univariable logistic regression
models. Since many of the factors of interest might be highly correlated, we assessed correlation
across variables and when present, only the variable with the strongest association with rotavi-
rus positivity was considered for the multivariable model. We then tested for two-way interac-
tions between each of the variables and age because risk factors are likely to be different for
infants. We conducted manual backwards stepwise elimination; the final multivariable model
included all variables and aimed to include interactions which retained statistical significance
at p<0.05. We report adjusted odds ratios (aOR) and 95% confidence intervals (CI) from the
final model as variables significantly associated with rotavirus. Collinearity was assessed in the
final model using condition index as described elsewhere [23, 24].
To assess bias, sensitivity analysis was performed by constructing additional models with
various subsets of the data. Children were eligible for re-enrollment as an MSD case after 90
days post enrollment. Therefore, it was possible for some children to be enrolled for more than
one episode of MSD. We constructed additional models excluding all observations for the 33
cases who were enrolled more than once, to ensure consistency of results and assess any poten-
tial bias. In addition, at enrollment, case stools were tested for a panel of enteric pathogens and
thus could have had more than one pathogen identified. We assessed models limited to the 86
cases who had rotavirus as a single pathogen and 159 cases who had rotavirus with other
enteric co-infections separately.
Additionally, to further evaluate clinical features’ associated with rotavirus, we applied a 17
point scoring system, referred to in this analysis as “GEMSmodified Vesikari score system” which
was adapted from the 20 point scale developed by Ruuska and Vesikari [25] to assess severity of
rotavirus diarrhea in a separate subgroup analysis which was different with the above models. The
score was calculated based on symptoms of diarrheal illness and the child’s characteristics at
enrollment. To compare clinical features and modified Vesikari scores we used chi square tests.
Assessment of seasonal patterns was limited to the first three years (36 months) of the study
where we had un-interrupted continuous and consistent monthly study enrollments that could
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support a seasonality analysis. We classified months for this period into cool and rainy (April,
May, June, September, October and November) and warm and dry (January, February, March,
July, August and December) based on the seasonal patterns in the study area. We compared
proportions of rotavirus positivity by season type and computed prevalence odds ratios and
confidence intervals using bivariate logistic regression. We further explored seasonality pattern
(probability of monthly stool samples testing positive for rotavirus) in a separate logistic regres-
sion model for the first three years of data where there was continuity using sine and cosine
functions of time [26].
Verbal cause of death (VA)
VA data collection and analysis methods used in this study has been described elsewhere in
detail [19, 27]. In brief, VA interviews were conducted by trained field workers using VA ques-
tionnaires. They interviewed the main caregiver of the deceased child on signs and symptoms
leading to the death and care seeking behavior during the illness. Information from these ques-
tionnaires were processed into Inter- VA -4 (version 4.02) program to obtain most probable/
underlying cause of death as further described elsewhere [28].
Ethics Statement
This evaluation is covered by the GEMS Kenya protocol which was approved by the scientific
and ethical review committees of KEMRI (KEMRI protocol # 1155) and the Institution Review
Board (IRB) of the University of Maryland, School of Medicine, Baltimore, MD USA (UMB
Protocol # H-28327). The IRB for the Centers for Disease Control and Prevention, Atlanta,
GA, USA formally deferred its review to the University of Maryland IRB (CDC Protocol #
5038). Written informed consent was obtained in the local dialect (i.e. Dholuo) from all partici-
pating caretakers before recruitment of their children into the study. Data were fully anon-
ymized at collection.
Results
Enrollment Profile
From January 31, 2008 to September 30, 2012, 1,778 MSD cases were enrolled in GEMS at the
Kenya site; 253 were positive for rotavirus. During the first three years of the study when we
had consistent enrollments without interruption, 1,476 MSD cases were enrolled. When strati-
fied by in-patient and out-patient type, children<12 months of age compared to children 23
to 59 months of age were at increased risk of rotavirus infection and the risk of infection
reduced by increasing child age regardless of patient type. During the three years period, dysen-
tery was significantly less commonly observed among any rotavirus positive (5/217 [2.3%]))
compared to negative (106/1,258 [8.4%]) MSD cases, odds ratio = 0.26; 95% confidence inter-
val (CI), 0.10–0.64, p = 0.003. Furthermore the pattern remained similar with dysentery being
observed to be less common among rotavirus-positive compared to negative MSD cases when
we stratified our analysis by in-patient and out-patient MSD cases. Among both in-patient and
out-patient MSD cases, the highest rotavirus isolation occurred in the first year of the study
with a decrease among in-patient but a stable rate of isolation among out-patient MSD cases in
the second and third years respectively (Table 1).
All dysentery cases from the four year study period were excluded from further analysis
including 8 (3.2%) rotavirus MSD cases, 132 (8.7%) rotavirus negative MSD cases and 1 rotavi-
rus-negative MSD case with unknown dysentery status (Fig 2). A total of 1,637 non-dysenteric
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MSD cases of whom 245 (15%) were rotavirus-positive and 1,392 rotavirus-negative were
included in further analyses as shown in Fig 2.
Breast feeding information presented in the current analysis was only available for the first
three years of the study and was available for 1,364 of the 1,476 MSD cases enrolled in that
period. In general 441 (32.3%) of the cases had stopped breastfeeding, 867 (63.6%) were par-
tially breastfed and 56 (4.1%) were exclusively breastfed. When we limited our analysis further
among 235 cases who at enrollment were aged<6 months and who were ideally expected to be
on exclusive breastfeeding, only 50 (21.3%) were exclusively breastfeeding, 180 (76.6%) were
partially breastfeeding and 5 (2.1%) had stopped breastfeeding. Exclusive breastfeeding was
less frequently reported among caretakers of rotavirus positive (8/59 [13.6%])) compared to
negative (42/176 [23.9%]) MSD cases, p = 0.095.
Factors associated with rotavirus infection
Compared with rotavirus-negative cases, rotavirus-positive cases were significantly younger
(median age; 8 vs 13 months p<0.0001). The majority (64%) of rotavirus-positive cases were
aged 0–11 months as shown in Table 2 and in Fig 3. Further patient demographics, clinical
characteristics and laboratory findings are listed in Table 2.
From birth prevalence increased to 20% at age 1 month and remained at more or less at the
same level through age 8 months, with a sharp drop-off in month 9, 10 and 11, see Fig 3.
Although some of the SHC did not have full in-patient facilities, patients in this study who
required more time for rehydration at the facility were retained in an improvised in-patient
unit sometimes called “ORS corner” for a few hours while undergoing further observation
while being rehydrated either through IV fluid or ORS. However in situations when further
complications or such patients required full hospitalization then they were referred appropri-
ately to the next level or superior health centers or hospitals with full in-patient services.
Table 1. Proportion of all rotavirus-positive vs negative stool samples from all GEMS children enrolled with MSD episodes within in-patient and
out-patient departments during the first 3 years of non-interrupted enrollment, western Kenya, Jan 2008-Feb 2011.
In-Patient MSD cases Out-Patient MSD cases
Characteristic Rotavirus
positive
Rotavirus negative P-value Rotavirus
positive
Rotavirus negative P-value
(N = 34) (N = 125) (N = 183) (N = 1,134)
n % n % OR95%CI n % n % OR95%CI
Child’s age stratum (in months)
0–11 23 67.6 54 43.2 † 0.01 114 62.3 482 42.5 5.41 [3.10–9.43] <0.0001
12–23 10 29.4 37 29.6 0.04 54 29.5 309 27.2 3.99 [2.21–7.23] <0.0001
24–59 1 2.9 34 27.2 Ref 15 8.2 343 30.2 Ref.
Median age in months 9 [IQR 6–13] 13 [IQR
8–24]
N/A 0.002 8 [IQR 5–15] 14 [IQR 8–27] <0.001
Dysentery
Yes 1 2.9 13 10.5 0.26 [0.03–2.05] 0.201 4 2.2 1041 91.8 0.25 [0.09–0.69] 0.007
No 33 97.1 111 89.5 Ref. 179 97.8 93 8.2 Ref.
Year of study
Year 1 15 44.1 65 52 Ref. 70 38.3 486 42.9 Ref. Ref
Year 2 10 29.4 37 29.6 1.17 [0.48–2.87] 0.755 56 30.6 390 34.4 0.99 [0.68–1.45] 0.987
Year 3 9 26.5 23 18.4 1.69 [0.65–4.40] 0.292 57 31.1 258 22.8 1.53 [1.05–2.24] 0.028
† Fisher`s exact test method used
doi:10.1371/journal.pone.0160060.t001
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Hospitalization was more commonly observed among MSD patients<1 year of age who were
rotavirus-positive versus negative (67.6% [25/37] vs. 46.3% [62/134], p<0.035) and among all
rotavirus-positive vs negative MSD cases regardless of age (15.1% [37/245] vs. 9.6% [134/
1,392], p<0.013). However, the overall length of stay in hospital was generally similar
(median = 2 days) for hospitalized rotavirus-positive and negative MSD cases. Other factors
that were associated with rotavirus MSD in univariable analysis include; vomiting3 times in
24 hours,7 loose stools in 24 hours, unable to drink, sunken eyes, irritability/restlessness,
lethargy, abnormal mental status and IV fluids given (Table 2).
Univariable and multivariable analysis
In univariable analysis, compared with rotavirus-negative cases, rotavirus-positive cases were
significantly more likely to present with sunken eyes (238/245 (97.1%) vs. 1,307/1,392 (93.9%),
OR = 2.21, 95%Confidence interval (CI): 1.01–4.84, p = 0.047); to be restless (179/245 (73.1%)
vs. 856/1,392 (61.5%), OR = 1.7,95%CI: 1.25–3.0, p = 0.0006); to have abnormal mental status
(186/245 (75.9%) vs. 874/1,392 (62.8%), OR = 1.87,95%CI:1.37–2.55, p<0.0001) and to be
unable to drink (16/245 (6.5%) vs. 44/1,392 (3.2%), OR = 2.14,95%CI:1.19–3.86, p = 0.011) and
to be hospitalized upon seeking care (37/245 (15.1%) vs. 134/1,392 (9.6%), OR = 1.67, 95%
CI:1.13–2.47,p = 0.01. Other factors associated with rotavirus infection included age, vomiting,
Fig 2. Flow diagram of enrollment of MSD cases in GEMS-Kenya, and the number of non-dysenteric MSD
rotavirus-positive and negative cases used for analysis, western Kenya 2008–2012.
doi:10.1371/journal.pone.0160060.g002
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number of loose stools, hospitalization and administration of IV fluids upon seeking care
(Table 2). Number of loose stools during the diarrheal illness were significantly correlated with
age, while intravenous fluid was correlated with fever, dehydration and admission. Receipt of
IV fluids and hospitalization were highly correlated and could not be included in the model
together. Only receipt of IV fluids was retained for model selection. In multivariable analysis,
younger age and vomiting3 times per day remained significantly associated with rotavirus
infection (Table 3). We found no statistically significant interactions between any of the vari-
ables that qualified for the multivariable model. In addition, sensitivity analysis of models
Table 2. Bivariate analysis of baseline characteristics of children with rotavirus-positive and rotavirus negative non-dysenteric MSD (n = 1637),
western Kenya, 2008–2012.
Rotavirus-positive Rotavirus-negative P-value
N = 245 N = 1,392
Characteristic n % n %
Child’s age stratum (in months)
0–11 156 63.7 626 45.0 <0.001
12–23 72 29.4 379 27.2 <0.001
24–59 17 6.9 387 27.8
Median age in months 8 [IQR 5–14] 13 [IQR 7–25] <0.001*
Gender
Female 120 49.0 591 42.5 0.058
Caretakers Education
R R
Formal education 125 51.0 606 43.6 0.118
Non-formal education 120 49.0 784 56.4
Clinical symptoms in the child at enrollment (% yes)
Vomiting3 times/24hrs 171 69.8 627 45.0 <0.001
Maximum no. of loose stools/24hrs
 7/24hrs 78 31.8 333 23.9 0.009
 6/24hrs 167 68.2 1059 76.1
Unable to drink 16 6.5 44 3.2 0.011
Sunken eyes 238 97.1 1307 93.9 0.047
Irritable/restlessness 179 73.1 856 61.5 <0.001
Lethargy 35 14.3 127 9.1 0.013
Child’s mental status abnormal§§ 186 75.9 874 62.8 <0.001
History of Fever (as observed by caretaker) 173 70.6 1076 77.3 0.024
Dehydration§
Moderate-to-severe‡ ‡ 55/241 22.8 250/1333 18.8 0.14
Mild ‡ 186/241 77.2 1083/1333 81.2
Child was admitted to hospital 37 15.1 134 9.6 0.01
IV ﬂuid given 43 17.6 155 11.1 <0.005
*p value based on Wilcoxon Rank Sums test
R R
= denominator = 1,635;
§§ = A child’s mental status was considered abnormal if restlessness or irritable or lethargy or unconsciousness was present or observed by clinician at
enrollment
§ A child was considered dehydrated if either mild or moderate to severe dehydration symptoms were present as described by the following classiﬁcations
‡ ‡ A child was considered moderately to severely dehydrated if 2 or more of the following were present: lethargic or unconscious on arrival/admission;
sunken eyes; drank poorly or unable to drink; skin pinch—goes back very slowly (>2 seconds)
‡ A child was considered mildly dehydrated if 2 or more of the following were present: Restless/irritable on arrival/admission; sunken eyes; thirsty, drank
eagerly; skin pinch—goes back slowly (1–2 seconds); ¶ = denominator is 1,574
doi:10.1371/journal.pone.0160060.t002
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excluding repeat enrollments and subsets of single and multiple pathogen positivity yielded the
same conclusions presented for the overall analysis, thus, data are not shown.
Finally using the GEMS modified Vesikari score at enrollment, we found that rotavirus-pos-
itive compared to negative cases were more likely to have a higher median Vesikari score (9 vs.
8), P<0.01 and were commonly observed to present with more severe disease symptoms.
(Table 4).
Mortality at sixty-day follow-up
Overall 1,580 (96.5%) of the 1,637 enrolled cases had their caretakers successfully interviewed
at 60-day follow-up. A higher proportion of rotavirus-positive (11/242 [4.5%]) compared to
negative (51/1,476 [3.5%]) cases died before the home visit follow-up interview, although the
differential in case fatality was not statistically significant (P = 0.36). VA cause of death infor-
mation was available for 60 MSD cases that including rotavirus-positive (10 [17%]) and nega-
tive (50 [83%]) cases that had died before follow-up. The causes of death among the 10
rotavirus-positive cases included: diarrhea 5 (50%), HIV 2 (20%), malaria 1 (10%), TB 1 (10%)
and parasitic disease 1 (10%). The causes of death among the 50 rotavirus-negative cases
included; diarrhea 13 (26%), HIV 13 (26%), malaria 13 (26%), malnutrition 5 (10%), pneumo-
nia 3(6%), TB 2 (4%) and measles 1 (2%). The median time from discharge to death was 12
(IQR) 7–18 days for rotavirus-positive MSD cases and 14 (IQR) 7–33 days for rotavirus-nega-
tive MSD cases P = 0.56
Fig 3. Rotavirus positivity among non-dysenteric MSD cases by age group, western Kenya 2008–2012.
doi:10.1371/journal.pone.0160060.g003
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Seasonality of rotavirus
For the first 3 years of the study, prevalence of non-dysenteric rotavirus-positive MSD cases by
year of study ranged from 14.2% (85/598) in the first year to 13.8% (63/457) in the second year
and finally to 20.7% (64/309) in the third year. Stool samples collected during usually warm
and dry months compared with usually cool and rainy months were twice as likely to be rotavi-
rus-positive, (142/691 [20.5%] vs 70/673 [10.4%]; OR = 2.16, 95%CI, 1.58–2.96). Although we
found that the proportion of cases positive for rotavirus was highest in August, December, Jan-
uary and February as shown in Fig 4, when we tested seasonality in a model using sine and
cosine functions of time, it revealed that the pattern of seasonality (probability that a stool sam-
ple would test positive for rotavirus) was significantly inconsistent across the 3 years of the
study period (P-value =<0.0001).
Discussion
In this study, we describe the epidemiology and factors associated with rotavirus infection
among patients<5 years of age in rural western Kenya, using comprehensive baseline and
60-day follow-up data. Our study finding that the risk of rotavirus infection was highest among
infants—an age group that accounted for more than 60% of rotavirus infections in our study is
consistent with other observations already made from other sub-Saharan African and Asian
countries [8, 29]. However, we did not detect any rotavirus cases in neonates but few neonates
with MSD were enrolled in our study.
Table 3. Crude and adjusted odds ratios of factors associated with rotavirus among children <5 years of age with non-dysenteric MSD, western
Kenya, 2008–2012.
Characteristic† Odds ratio (OR) for being ELISA positive for rotavirus diarrhea [95% conﬁdence interval (CI)]
Child’s age stratum (in months) Unadjusted Odds Ratio (OR) 95% CI Adjusted Odds Ratio (aOR) 95% CI
0–11 5.67 (3.38–9.51) 5.29 (3.14–8.89)
12–23 4.32 (2.50–7.47) 4.08 (2.35–7.07)
24–59 Ref †† Ref
Gender
Female 1.3 (0.99–1.71)
Male Ref Ref
Clinical symptoms in the child at enrollment
Vomiting3 times/24hrs
Yes 2.82 (2.10–3.78) 2.66 (1.98–3.57)
No Ref Ref
Maximum no. of loose stools/24hrs
 7/24hrs 1.49 (1.10–2.00)
 6/24hrs Ref Ref
Dehydration
Moderate-to-severe 1.28 (0.92–1.78)
Mild Ref Ref
IV ﬂuid given
Yes 1.7 (1.17–2.46)
No Ref Ref
† 6 variables initially entered into the model out of which 2 (above) were associated with rotavirus positivity. Variables dropped were 4 namely; Child offered
IV ﬂuid, dehydration, Maximum stool in 24hrs and gender
††Ref denotes the referent group
doi:10.1371/journal.pone.0160060.t003
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Clinical assessment, treatment and decision for admission of diarrhea patients to a hospital
can be influenced by differences in socio-economic factors, or by clinician’s attitudes. In the
current study, rotavirus cases among children<1 year also had an increased likelihood of hos-
pitalization compared to rotavirus-negative infants, an observation we argue may have not
been biased by test results, since stool testing is batched and results are not available to clini-
cians who decide on hospitalization and treatment until later in the clinical course. Our current
study demonstrates that the proportion of infants infected with rotavirus among out-patients
was higher compared to children 24–59 months of age. Furthermore among in-patient study
population, infants were at the greatest risk of hospitalization, followed by children 12–23
months of age compared to children 24–59 months of age. Consistent with other studies, rota-
virus diarrhea has been shown to be a major cause of hospitalization mostly in infants [30].
Table 4. Numerical (GEMSmodified) scoring system for severity of diarrhea among rotavirus-positive and negative children with non-dysenteric
MSD, western Kenya, January 31, 2008-September 30, 2012.
Child characteristics Points assigned Rotavirus-positive Rotavirus-negative p-value
(N = 17) N = 245 N = 1,392
N % n %
Duration of diarrhea (days)
1–4 1 221 90.2 1,247 89.6 0.954
5 2 14 5.7 85 6.1
6 3 10 4.1 60 4.3
Max no. diarrhea/24 hrs.
3–6 2 167 68.2 1,059 76.1 0.010
7 3 78 31.8 333 23.9
Vomited 3+ times/24 hrs.
Yes 3 171 69.8 627 45.0 <0.001
No 0 74 30.2 765 55.0
Fever †
<37.0 0 82 33.5 550 39.5 <0.001
37.1–38.4 1 128 52.2 534 38.4
38.5–38.9 2 17 6.9 112 8.1
> = 39 3 18 7.4 195 14.0
Dehydration††
Moderate/Severe‡‡ 3 55 22.8 250 18.8 0.156
Mild‡ 2 186 77.2 1,083 81.2
Treatment
Out-patient without IV ﬂuid 0 198 80.8 1,215 87.3 0.023
Out-patient with IV ﬂuid 1 10 4.1 43 3.1
Hospitalization with or without IV ﬂuid 2 37 15.1 134 9.6 0.013
Median Score ††† N/A 9 [IQR] 8–10 8 [IQR] 6–10 <0.001
† Denominator = 1,636
†† Denominator = 1,574
†††Median calculated for children not missing information (rotavirus-positive = 241 and rotavirus negative = 1,332)
‡ A child was considered mildly dehydrated if 2 or more of the following were present: Restless/irritable on arrival/admission; sunken eyes; thirsty, drank
eagerly; skin pinch—goes back slowly (1–2 seconds)
‡‡ A child was considered moderately to severely dehydrated if 2 or more of the following were present: lethargic or unconscious on arrival/admission;
sunken eyes; drank poorly or unable to drink; skin pinch—goes back very slowly (>2 seconds)
doi:10.1371/journal.pone.0160060.t004
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In our current study as seen elsewhere [11], clinically diagnosed fever by our study clinicians
was associated with rotavirus diarrhea. However, when we asked caretakers separately whether
they had observed history or presence of fever during their child’s diarrheal episode, the care-
takers reported fever was seen to be more common among rotavirus-negative compared to
positive MSD cases suggesting that caretakers may have not been either keenly observant of
fever or may have not recognized fever to be related to the diarrheal illness. Our previous
healthcare utilization and attitude survey, conducted before hospital-based surveillance began,
revealed that fever was not among the factors that prompted caretakers to seek care for their
child`s diarrheal illness[20]. This observation may in part explain the lack of appreciation by
caretakers in this community that fever and diarrhea may be related.
Our modified GEMS clinical scoring system adapted from the Vesikari score system [25]
enabled us to assess the severity of rotavirus compared to non-rotavirus MSD. As shown in our
study and consistent with findings across many settings, in young children, rotavirus disease is
characterized by diarrhea, vomiting, and severe dehydration [31]. The overall median severity
score was significantly higher among rotavirus positive than negative cases and similar obser-
vations have been made in other studies elsewhere [32, 33]. We also observed that diarrhea
severe enough to lead to hospitalization was prevalent among the infants and young children
diagnosed with rotavirus disease—a finding that is consistent with observations previously
made elsewhere[33] and also by the World Health Organization [31]. Overall our current
Fig 4. The seasonal distribution of rotavirus-positive compared with negative cases among children with non-dysenteric
moderate-to-severe diarrhea (MSD) in western Kenya, January, 2008- February, 2011.
doi:10.1371/journal.pone.0160060.g004
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study shows that there was generally very little exclusive breastfeeding, with almost 80% of
MSD cases aged<6 months either partially breastfeed or had stopped breastfeeding. Further-
more, although not statistically significant, exclusive breastfeeding was less frequently reported
among caretakers of rotavirus positive (13.6%) compared to negative cases (23.9%)—an obser-
vation which is not dissimilar to that made in other settings[33]. These findings may suggest
that maternal antibodies could be insufficient to protect against severe rotavirus illness. Second,
the age-associated differences observed in rotavirus prevalence, including the less common
rotavirus occurrence among breastfed children aged<6 months and those aged<4 months as
observed in our study is worth noting. Infants receive passive protection from trans-placental
and breastmilk antibodies for the first 6 months of life. Infants who continue to exclusively
breastfeed are less likely to be exposed to pathogens than infants on mixed feedings during the
six months of age [34]. The child’s first exposure to a rotavirus infection during the first six
months of life often results in severe disease due to lack of antibodies to fight the infection and
is more likely to lead to hospitalization as our current findings suggest since passive immunity
wanes and natural immunity acquired from such exposure builds up; subsequent infections
tend to produce milder illness which may be characterized by less severe disease and admission
to hospital as suggested by our data. Therefore as we have observed in this study and as shown
from other settings, the rate of illness declines as the child’s age increases and probably as chil-
dren acquire immunity increasingly from subsequent rotavirus infections[35].
Active, sentinel surveillance of rotavirus diarrhea could provide useful data that can guide
the interpretation of diarrheal disease trends following rotavirus vaccine introduction in set-
tings such as Kenya. During the first 3 years of year surveillance, we found rotavirus prevalence
rate of 14.2% in year 1 and which remained stable in year two (13.8%) but increased to 20.7%
in year 3 among children seeking care at a hospital or health center for non-dysenteric MSD.
Our prevalence rate of rotavirus among MSD patients<5 years in year one and two of the sur-
veillance is slightly higher but remains comparable to a prevalence of 12% reported from a pop-
ulation-based surveillance study conducted in both urban slums in Nairobi and rural western
Kenya [36] and to 13.5% from a similar study conducted in Nigeria [37]. Furthermore, our
observed prevalence especially in year 3 is similar to that observed in other hospital-based stud-
ies conducted in the neighboring countries like Tanzania (21%) [10]and Ethiopia (21%) [38].
However, our reported prevalence of rotavirus is relatively lower than other observations from
other studies conducted in Africa; for example 33% in Burkina Faso[9] and 45% in Uganda
[32]. The differences observed across these studies may be explained by differences in study
methodologies including variations in seasonality, study periods, study populations and possi-
bly laboratory techniques. However the observed variations in rotavirus rates further highlights
the need and importance of national and regional standardization of rotavirus surveillance
using different approaches and techniques that can support comparison and monitoring of
rotavirus trends post-vaccine implementation and to perform vaccine impact assessment and
cost-effective analyses.
Studies from other countries within and outside Africa have shown that rotavirus vaccines
are safe, effective and cost-effective interventions against severe rotavirus disease [29]. Follow-
ing implementation of rotavirus vaccination, remarkable declines in overall diarrhea occur-
rence and hospitalization associated with rotavirus diarrhea have occurred in a number of both
developed and a few developing countries [39–41]. Vaccination is currently the best way to
prevent severe rotavirus illness, particularly in settings such as our study area where access to
medical care is limited or sometimes unavailable [31] and ORT use is low[20, 39]. Furthermore
in countries with poor immunization programs, as in many African countries, administration
of vaccine doses may be delayed. The cost-effectiveness of the rotavirus vaccine declines rapidly
with a delayed administration of the first rotavirus vaccine dose which highlights the need for
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strong immunization programs. With support from GAVI, in July 2014, Kenya implemented
routine rotavirus vaccination under the country’s national infant immunization program. To
realize its full life-saving potential, rotavirus vaccination must reach all vaccine-eligible
children.
Although it has been estimated that rotavirus vaccine introduction in Kenya could prevent
more than 5,000 hospitalizations and over 800,000 clinic visits among children<5 years annu-
ally [42], results would be optimized when complementary interventions such as increasing
use of oral rehydration salts (ORS) and exclusive breastfeeding among children< 6 months
and those with diarrhea are also strengthened. Dehydration can be reversed through oral rehy-
dration therapy (ORT) (that is continued feeding and fluids including breastfeeding and ORS
use at home) or, if more serious, through hospitalization and IV fluids. Furthermore ORT is
important in management of rotavirus diarrhea as antibiotics or other drugs have no known
benefit on treating such an illness or acute watery diarrhea due to cholera, cryptosporidiosis,
and many other similar illnesses. Our finding that there was no difference between all-cause
deaths among children with rotavirus compared to non-rotavirus MSD at sixty day follow-up
is an important observation that could possibly highlight that mortality is not associated with
rotavirus in hospital based studies. This is possible because detection of rotavirus generally
requires a visit to clinic, which presumably would lead to rehydration, but non-detected rotavi-
rus cases that did not make it to a clinic would be less likely to access rehydration and may die
in the community without seeking care. When examining the verbal autopsy data, we were not
powered to compare diarrhea deaths between rotavirus and non-rotavirus MSD cases at the
60-day follow-up visits. However our VA data presented in this analysis has shown that deaths
from rotavirus-positive compared to those from negative MSD cases occurred a few days after
enrollment which further suggests that children who reach a healthcare facility with acute rota-
virus diarrhea may recover sooner than non-rotavirus MSD cases. Our findings further sug-
gests that diarrhea was the leading cause of death among children with moderate-to-severe
diarrhea in our study population—an observation that may suggest that diarrhea continues to
be a leading cause of morbidity and mortality in this setting.
Our study is subject to biases and limitations. Data from this study may not be generalized
to all children<5 years in Kenya as it was conducted in a single rural site in western Kenya.
Also, our modified Vesikari score needs to be interpreted with caution. In our study, informa-
tion on the duration of vomiting and the maximum number of episodes of vomiting over a
24-hour period was not collected because the caretakers were interviewed only at study enroll-
ment. The incomplete capture of information on vomiting in our study did not allow us to cal-
culate the full 20-point Vesikari score. We resolved this by modifying the Vesikari score based
on GEMS data and we were able to construct a 17-point scoring system instead.
As rotavirus vaccine is introduced into the Kenya national immunization program, moni-
toring its impact on diarrheal disease burden, clinical presentation, and seasonality will be
important.
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